These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 31487183

  • 41. High-throughput kinetic turbidity analysis for determination of amorphous solubility and excipient screening for amorphous solid dispersions.
    Fan Y, Castleberry S.
    Int J Pharm; 2023 Jan 25; 631():122495. PubMed ID: 36526147
    [Abstract] [Full Text] [Related]

  • 42. A Mechanistic Model for Predicting the Physical Stability of Amorphous Solid Dispersions.
    Ojo AT, Lee PI.
    J Pharm Sci; 2021 Apr 25; 110(4):1495-1512. PubMed ID: 32818440
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
    Prasad D, Chauhan H, Atef E.
    J Pharm Sci; 2014 Nov 25; 103(11):3511-3523. PubMed ID: 25196860
    [Abstract] [Full Text] [Related]

  • 45. Solubility advantage from amorphous etoricoxib solid dispersions.
    Dani P, Puri V, Bansal AK.
    Drug Dev Ind Pharm; 2014 Jan 25; 40(1):92-101. PubMed ID: 23301771
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Dicarboxylic acid as a linker to improve the content of amorphous drug in drug-in-polymer film: Effects of molecular mobility, electrical conductivity and intermolecular interactions.
    Quan P, Wan X, Tian Q, Liu C, Fang L.
    J Control Release; 2020 Jan 10; 317():142-153. PubMed ID: 31785302
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Building a better particle: Leveraging physicochemical understanding of amorphous solid dispersions and a hierarchical particle approach for improved delivery at high drug loadings.
    Schenck L, Mann AKP, Liu Z, Milewski M, Zhang S, Ren J, Dewitt K, Hermans A, Cote A.
    Int J Pharm; 2019 Mar 25; 559():147-155. PubMed ID: 30654058
    [Abstract] [Full Text] [Related]

  • 53. Impact of Polymer Type and Relative Humidity on the Long-Term Physical Stability of Amorphous Solid Dispersions.
    Lehmkemper K, Kyeremateng SO, Heinzerling O, Degenhardt M, Sadowski G.
    Mol Pharm; 2017 Dec 04; 14(12):4374-4386. PubMed ID: 29050468
    [Abstract] [Full Text] [Related]

  • 54. Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions.
    Wegiel LA, Mauer LJ, Edgar KJ, Taylor LS.
    J Pharm Pharmacol; 2014 Feb 04; 66(2):244-55. PubMed ID: 24433425
    [Abstract] [Full Text] [Related]

  • 55. Amorphous solid dispersion of ibuprofen: A comparative study on the effect of solution based techniques.
    Ziaee A, O'Dea S, Howard-Hildige A, Padrela L, Potter C, Iqbal J, Albadarin AB, Walker G, O'Reilly EJ.
    Int J Pharm; 2019 Dec 15; 572():118816. PubMed ID: 31678527
    [Abstract] [Full Text] [Related]

  • 56. Investigation of Ethylene Oxide-co-propylene Oxide for Dissolution Enhancement of Hot-Melt Extruded Solid Dispersions.
    Hurley D, Potter CB, Walker GM, Higginbotham CL.
    J Pharm Sci; 2018 May 15; 107(5):1372-1382. PubMed ID: 29410037
    [Abstract] [Full Text] [Related]

  • 57. Insights into co-amorphous systems in therapeutic drug delivery.
    Singh R, Joshi V, Mehetre N, Sangamwar AT.
    Ther Deliv; 2021 Mar 15; 12(3):245-265. PubMed ID: 33745286
    [Abstract] [Full Text] [Related]

  • 58. Fed- and Fasted-State Performance of Pretomanid Amorphous Solid Dispersions Formulated with an Enteric Polymer.
    Nguyen HT, Van Duong T, Jaw-Tsai S, Bruning-Barry R, Pande P, Taneja R, Taylor LS.
    Mol Pharm; 2023 Jun 05; 20(6):3170-3186. PubMed ID: 37220082
    [Abstract] [Full Text] [Related]

  • 59. Co amorphous systems: A product development perspective.
    Chavan RB, Thipparaboina R, Kumar D, Shastri NR.
    Int J Pharm; 2016 Dec 30; 515(1-2):403-415. PubMed ID: 27771485
    [Abstract] [Full Text] [Related]

  • 60. Hydroxypropyl cellulose stabilizes amorphous solid dispersions of the poorly water soluble drug felodipine.
    Sarode AL, Malekar SA, Cote C, Worthen DR.
    Carbohydr Polym; 2014 Nov 04; 112():512-9. PubMed ID: 25129775
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.